Notably, other studies have found α2-macroglobulin levels to be higher in plasma from AD patients [33] and transthyretin and transferrin levels to be lower in serum from AD patients than controls [34], [35], consistent with the findings from the ADNI plasma dataset. This evidence concerns the gene TTR and Alzheimer disease.